Forward Science hires Vice President of Finance to Support Company Growth

STAFFORD, Texas - June 1, 2016 - PRLog -- (Houston, TX) Forward Science hired Daniel Llerena as the Vice President of Finance. With the continued growth at Forward Science, the company needed a financial executive with healthcare experience to streamline processes and maximize potential. Daniel will fill the role of the financial expert during the Company's launch of new products.

"We are truly excited to have someone of his background on the team" explains Robert J. Whitman, Forward Science Co-Founder and CEO. "With his experience at two of the big 4 accounting firms, Daniel brings a skillset that is unique to smaller companies. "With his work ethic and experience, we believe his role at Forward Science will grow as we continue to evolve as a Company."

Daniel joins the Forward Science team with over ten years experience in Financial Services. After graduating from the University of Florida with a Masters in Accounting, Daniel joined Deloitte's Miami office. After six years with Deloitte, Daniel relocated to Houston, TX to work for Ernst & Young. Working in the Ernst & Young, Daniel had some of the largest healthcare companies in the region as his clients and continued to excel where he reached the level of Senior Manager. After 4 years, Daniel decided to start a new chapter in his career as Vice President of Finance for a fast growing biotech company, Forward Science.

"After 10 years in public accounting, the opportunity to join Forward Science presented itself and I could not turn it down" explained Daniel during his transition to Forward Science. "I am happy to be a part of the team and excited for what the future holds for our Company as we continue to grow and excel."

About Forward Science

Forward Science is a privately held biotechnology company based in Houston, Texas. OralID, Forward Science's flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Save Lives. by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life Program includes the following in effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX). SalivaMAX is Forward Science's latest product offering, which is an FDA cleared prescription strength rinse for all ranges of Xerostomia.

To learn more about Forward Science's ID For Life Program, or any of their products, visit http://www.oralid.com or call 855-696-7254.